| Summary: | The main cause of death of the person with type 2 diabetes mellitus is cardiovascular. Its prevention involves an integrated management of all risk factors.
Objective: To evaluate the results of an intervention to improve the outcome of patients with type 2 diabetes debut and a history of hypertension that were treated with betablockers at the Chiqui Lubián Gomez University Polyclinic.
Material and Method: prospective quasi-experimental study in an intentional sample of 22 patients with type 2 diabetes mellitus debut and a history of hypertension who attended the multidisciplinary consultation of diabetes mellitus in the period from January to December 2011.
Results: there was a prevalence of female patients -16 patients (72.7%) - and the age group between 50 and 69 years - (77.2%). The hypertension control was achieved with a change to inhibitors of angiotensin converting enzyme (90.9%). Metabolic control, by quarter, improved significantly until reaching a 95.4% in the last one. Favorable changes in lifestyle, such as incorporating the practice of physical exercises (81.8%), were achieved. They ensure a better quality of life. With regard to body weight, at the start of the intervention there were 12 (54.5%) overweight patients and at the end they were reduced to seven (31.8%). It was possible that 100% of patients had a proper diet to control the disease, but only one patient (18.1%) stopped smoking, which is not significant. Better results could be achieved in the long term. Generally, the intervention was successful in 90.9% of patients.
Conclusions: Patients presenting with type 2 diabetes mellitus and a history of hypertension evolve favorably with a treatment of angiotensin converting enzyme inhibitors as hypotensive and good metabolic control with lifestyle changes.
|
|---|